Neurology Minute
2,030 episodes — Page 8 of 41
Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge
Dr. Katie Krulisky and Dr. Leah Blank discuss the impact of outpatient follow-up on readmission rates for older adults with epilepsy or seizures. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213638
Biopsy-Confirmed Small Vessel Primary CNS Vasculitis - Part 3
In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Sumanth Reddy discuss his team's findings on the treatment approach presented in this paper. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200397
Biopsy-Confirmed Small Vessel Primary CNS Vasculitis - Part 2
In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Sumanth Reddy discuss how patients with amyloid-beta–related angiitis present. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200397
Seizure Action Plans in Pediatric Convulsive Status Epilepticus - Part 2
In the concluding segment of this series, Dr. Halley Alexander and Dr. Coral M. Stredny delve into the essential components of seizure action plans and identify the individuals who should have one. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200449
Seizure Action Plans in Pediatric Convulsive Status Epilepticus - Part 1
In part one of this two-part series, Dr. Halley Alexander and Dr. Coral M. Stredny discuss the importance of seizure action plans and how this might translate into our clinical care. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200449
Clinical Reasoning Series: Intracerebral Hemorrhage and Tortuous Retinal Arterioles
Dr. Nadia Khalil and Dr. Jean Bouchart discuss the diagnostic approach to intracerebral hemorrhage, the causes of cerebral small vessel disease, and the interpretation of biomolecular tests. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209796
Functional Seizures and Driving - Part 3
In the final episode of this three-part series, Dr. Jodie Roberts and Dr. Urs Fisch discuss functional/dissociative seizures and driving risk. Learn more about the Neurology® Practice Current section and fill out the current survey on functional/dissociative seizures and driving.
Functional Seizures and Driving - Part 2
In part two of this three-part series, Dr. Jodie Roberts and Dr. Barbara A. Dworetzky discuss how often seizure-like or seizure-resembling episodes lead to a diagnosis of functional neurologic disorder. Learn more about the Neurology® Practice Current section and fill out the current survey on functional/dissociative seizures and driving.
Functional Seizures and Driving - Part 1
In part one of this three-part series, Dr. Jodie Roberts and Dr. Barbara A. Dworetzky discuss the term "functional seizures" and clarify the terminology. Learn more about the Neurology® Practice Current section and fill out the current survey on functional/dissociative seizures and driving.
Biopsy-Confirmed Small Vessel Primary CNS Vasculitis - Part 1
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Sumanth Reddy discuss small vessel primary CNS vasculitis. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200397
Clinical Criteria for LATE
Dr. Greg Cooper and Dr. David A. Wolk discuss limbic predominant age-related TDP-43 encephalopathy (LATE), covering its clinical features, diagnostic criteria, and more. Show reference: https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.14202
Optic Nerve Imaging - Part 2
In the second installment of this three-part series, Dr. Elizabeth Zollos discusses the use of magnetic resonance imaging (MRI) in multiple sclerosis diagnosis.
Introduction to the New AAN President, Natalia S. Rost, MD, MPH, FAAN, FAHA
In the first episode of the AAN President's Spotlight series, Dr. Jason Crowell speaks with the new AAN President, Dr. Natalia S. Rost, as she outlines her vision and key priorities for her two-year term. Show references: https://www.aan.com/about-the-aan/presidents-spotlight
False Positivity of Acetylcholine Receptor Autoantibodies in Clinical Practice - Part 2
In part two of this two-part series, Dr. Stacey Clardy and Dr. Elia Sechi discuss how to approach the management of patients in clinic when there is concern for a possible false positive on the radioimmunoprecipitation assay for the acetylcholine receptor antibody. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213498
False Positivity of Acetylcholine Receptor Autoantibodies in Clinical Practice - Part 1
In part one of this two-part series, Dr. Stacey Clardy and Dr. Elia Sechi discuss the clinical scenarios where the commonly used assay for myasthenia gravis is most likely to produce false positive results in patients who do not actually have myasthenia gravis. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213498
Transforming Neurology Education: Evaluating Teaching Incentive Programs
Dr. Roy E. Strowd and Dr. Susannah Cornes discuss a teaching incentive initiative designed to support and reward faculty in academic neurology. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200182
Optic Nerve Imaging - Part 1
In the first installment of this three-part series, Dr. Elizabeth Zollos explores how optical coherence tomography is advancing our understanding of multiple sclerosis and enhancing diagnostic accuracy.
Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 2
In part two of this two-part series, Dr. Jeff Ratliff and Dr. Per Borghammer explore the subcategories of Lewy body disease, focusing on the body-first subtype Show reference: https://www.nature.com/articles/s41593-025-01910-9
AAN's President's Award Recipient for 2025 - Part 2
In the second installment of this two-part series, Dr. Stacey Clardy and Dr. Janis Miyasaki discuss how she got involved with the AAN. Show reference: https://www.aan.com/news/aan-honors-leader-volunteer-2025-presidents-award
Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 1
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Per Borghammer examine the dichotomy that existed before his team began this project. Show reference: https://www.nature.com/articles/s41593-025-01910-9
AAN's President's Award Recipient for 2025 - Part 1
In the first installment of this two-part series, Dr. Stacey Clardy engages in a thought-provoking conversation with Dr. Janis Miyasaki, asking her to share two invaluable pieces of wisdom. Show reference: https://www.aan.com/news/aan-honors-leader-volunteer-2025-presidents-award
Progressive Multiple Sclerosis
Dr. Jeff Lambe talks about progressive multiple sclerosis. Show references: https://journals.lww.com/co-neurology/abstract/2025/06000/re_defining_progression_in_multiple_sclerosis.4.aspx https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00281-8/abstract https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(14)70256-X/abstract https://www.tandfonline.com/doi/full/10.1080/14737175.2022.2143265 https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0288967 https://jamanetwork.com/journals/jamaneurology/article-abstract/2809772 https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
Neuroimmunology Update 2025: Autoimmune Encephalitis Outcomes
Dr. Justin Abbatemarco discuss autoimmune encephalitis with a focus on outcomes. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000210109 https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00463-5/abstract
Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 2
In part two of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss handling patient requests for blood-based biomarkers for Alzheimer disease and interpreting test results.
Spontaneous Intracranial Hypotension Updates
Dr. Jessica Ailani and Dr. Kathleen Digre discuss the evolution of spontaneous intracranial hypotension (SIH) diagnosis and treatment over the past decade.
Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 1
In part one of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss current biomarkers for Alzheimer disease and how do you use them in clinic.
Neuroimmunology Update 2025: MOGAD Treatments
Dr. Justin Abbatemarco discusses updates around MOGAD treatments. Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2822964 https://jnnp.bmj.com/content/95/11/1054
Neuroimmunology Update 2025: Autoimmune Encephalitis Outcomes
Dr. Justin Abbatemarco discusses autoimmune encephalitis with a focus on outcomes. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000210109 https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00463-5/abstract
The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting
Dr. Halley Alexander discusses the Neurology Today article, "The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting," by Gina Shaw, available in the latest issue of Neurology Today or at neurologytoday.com. Show reference: The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting
Diagnosis of Alzheimer Disease Using Plasma Biomarkers
Dr. Greg Cooper and Dr. Joseph Therriault discuss the use of plasma biomarkers in diagnosing Alzheimer disease. Show reference: https://doi.org/10.1038/s43587-024-00731-y
Women With Genetic Epilepsies
Dr. Halley Alexander and Dr. Paula Marques discuss sex differences in genetically determined epilepsies. Show reference: https://www.neurology.org/doi/10.1212/NXG.0000000000200233
Neuroimmunology Update 2025: AQP4+ NMOSD Treatment Landscape
Dr. Justin Abbatemarco discusses updates around treatments in AQP4+ NMOSD. Show references: https://pubmed.ncbi.nlm.nih.gov/38760098/ https://www.neurology.org/doi/10.1212/NXI.0000000000200071
BTK Inhibitors in Multiple Sclerosis Treatment - Part 3
In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how to address questions related to BTK Inhibitors with patients. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
BTK Inhibitors in Multiple Sclerosis Treatment - Part 2
In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss the clinical trial data available in both the relapsing and progressive cohorts. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
BTK Inhibitors in Multiple Sclerosis Treatment - Part 1
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how Bruton Tyrosine Kinase (BTK) Inhibitors work and how they vary from other disease-modifying therapies. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
Dr. Justin Abbatemarco provides an update on autologous hematopoietic stem cell transplantation in multiple sclerosis. Show reference: https://www.nature.com/articles/s41582-024-01050-x
Women History Minute - Mary A. B. Brazier
In this women's history minute, Dr. Alison Christy discusses the life and legacy of Mary A. B. Brazier.
The Landscape of Adult Neurology Residency Didactic Curricula in the United States - Part 2
In part two of this two-part series, Dr. Jeff Ratliff and Dr. Harry Sutherland discuss the diverse strategies that residency programs implement to ensure residents can continue their education in a protected and supportive environment. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200205
The Landscape of Adult Neurology Residency Didactic Curricula in the United States - Part 1
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Harry Sutherland discuss how neurology residency programs are incorporating didactic teaching methods to enhance learning outside the clinical environment. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200205
Characterizing Prodrome in Migraine
Dr. Jessica Ailani and Dr. Richard B. Lipton discuss the significance of recognizing prodromal symptoms, the findings from the PRODROME trial, and the implications for clinical practice. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200359
Estrogen Exposure from Modern Hormonal Contraceptives and Vascular Risk in Women with Migraine: A Nationwide Electronic Health Record Database Study
Dr. Tesha Monteith discusses an abstract that was presented at the AAN Annual Meeting titled, "Estrogen Exposure from Modern Hormonal Contraceptives and Vascular Risk in Women with Migraine: A Nationwide Electronic Health Record Database Study." Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-002306.html
The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy - Part 4
In the final episode of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss the abstract she presented at the AAN Annual Meeting and details on the upcoming gene therapy trial. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000208987
Reducing Health Care Costs with Functional Seizures Clinic Referral
Prof. Jon Stone, Dr. Laura Strom, and Meagan Watson discuss functional seizures and healthcare costs related to the functional seizure program at the University of Colorado. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200393
Neurology® Open Access - Part 2
Neurology® Open Access has officially launched! In part two of this two-part series, Dr. Jeff Ratliff and Dr. Amy C. Kunchok discuss the advantages of an open-access publication model. Read the related editorial in Neurology® Open Access.
Neurology® Open Access - Part 1
Neurology® Open Access has officially launched! In part one of this two-part series, Dr. Jeff Ratliff and Dr. Amy C. Kunchok discuss the scope and focus of Neurology® Open Access (NOA). Read the related editorial in Neurology® Open Access.
The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy - Part 3
In part two of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss current treatment options for Leber hereditary optic neuropathy (LHON). Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-002206.html
The Latest Data from Lenadogene Nolparvovec Gene Therapy Trials for Leber Hereditary Optic Neuropathy -Part 2
In part two of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss current treatment options for Leber hereditary optic neuropathy (LHON). Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-002206.html
A Discussion with Dr. Gebreyohanns: 2025 Ted Burns Humanism in Neurology Award - Part 2
In part two of this two-part series, Dr. Jeff Ratliff and Dr. Mehari Gebreyohanns discuss the essence of humanistic care.
A Discussion with Dr. Gebreyohanns: 2025 Ted Burns Humanism in Neurology Award - Part 1
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Mehari Gebreyohanns discuss the Bahir Dar Outreach for Neurology Education (BORNE) initiative.
Trends and Disparities in the Utilization of Thymectomy for MG in the US
Dr. Gordon Smith and Dr. Jennifer Morganroth discuss the trends in thymectomy utilization for myasthenia gravis. References: https://www.neurology.org/doi/10.1212/CPJ.0000000000200335